NA Proactive news snapshot: NetCents Technology, CytoDyn, Co-Diagnostics, Empower Clinics …

NA Proactive news snapshot: NetCents Technology, CytoDyn, Co-Diagnostics, Empower Clinics …

Proactive Investors

Published

NetCents Technology Inc (CSE:NC) (OTCMKTS:NTTCF), the cryptocurrency payments specialist, said Thursday that it has struck an enterprise agreement with Link Global Technologies Inc (CSE:LNK) to work together to create a dynamic "fixed-income" type product for investors looking for strong returns with a short 365-day time horizon. The Toronto-based company said clients will purchase units that will “generate returns through bitcoin mining” with more concrete details to follow, but returns are projected to “exceed 25% over a 12-month horizon.” "I am extremely excited to help bring such an exciting product to market," NetCents Technology CEO Clayton Moore said in a statement. CytoDyn Inc (OTCMKTS:CYDY) announced Thursday that two coronavirus patients have been treated with its investigational new drug leronlimab. In a statement, the group said the treatment was administered at a leading medical center in the New York City area under the emergency Investigational New Drug (IND) order recently granted by the US Food and Drug Administration. Leronlimab is intended to serve as a therapy for patients who experience respiratory illness as a result of contracting the coronavirus disease (COVID-19). Co-Diagnostics Inc (NASDAQ:CODX) announced Thursday that CoSara Diagnostics Pvt Ltd, its joint venture based in India, has become the first company in the country to receive a license to manufacture coronavirus (COVID-19) test kits.  The company plans to sell its RT-PCR COVID-19 tests in the Indian market as well as the surrounding region. CoSara received expedited approval for its license from India’s Central Drugs Standards Control Organisation (CDSCO), thanks to its involvement with the “Make in India” initiative, a country-wide effort to transform India into a design and manufacturing hub. Empower Clinics Inc (CSE:CBDT) (OTCMKTS:EPWCF), the vertically integrated health and life sciences firm, has told investors that patient visits to its corporate clinics continue at a record pace amid the coronavirus outbreak. The company runs a network of physician-staffed wellness clinics and, as reported earlier this month, patient visits increased by 800% in February compared to the same month in 2019. On March 4, Empower reported that total patient visits came in at 1,817 in February 2020 compared to 227 in February 2019. Bragg Gaming Group Inc (CVE:BRAG) (OTCMKTS:BRGGF) told shareholders Thursday that “growth is ongoing” thanks to a strong first-quarter performance and record revenues. The company’s comments came in a business update in light of the global coronavirus pandemic, which has caused a worldwide health crisis and disrupted financial markets around the world. Toronto-based Bragg said that its management is “actively tracking” the impact of the virus on the gaming industry and has not made any amendments to their 2020 guidance. Lexaria Bioscience Corp (OTCMKTS:LXRP) (CSE:LXX), a specialist in drug delivery technology, revealed Thursday that it has initiated a program with top labs in the United States and Canada to study the benefits of the company’s DehydraTECH drug delivery platform for boosting the delivery and effectiveness of certain antiretroviral drugs being tapped in the fight against the coronavirus (COVID-19). Researchers are currently investigating different antiretroviral drugs as potential candidates to combat the disease. Kincora Copper Ltd (CVE:KCC) told investors it has closed its earlier announced deal with RareX Ltd concerning copper-gold assets in New South Wales, firing the starting gun on the company carrying out high impact drilling at a number of targets in Australia's foremost porphyry belt. Kincora now has a controlling interest across 1,732 square kilometres (km) in the key belts of the Macquarie Arc, with a pipeline of targets being systematically advanced. Perma-Fix Environmental Services Inc (NASDAQ:PESI) swung to a profit in its latest quarterly results as the nuclear services company nearly doubled revenue thanks to triple-digit growth from its services segment. The Atlanta-based firm posted revenue of $22.1 million during the fourth quarter, an 88.1% increase from the $11.7 million figure it posted in the same period a year earlier. Its services segment saw revenue increase by 341% to $11.8 million compared to $2.7 million over the same period a year prior. Arcadia Biosciences Inc. (NASDAQ:RKDA) announced Thursday a new strategic partnership with two companies to introduce its GoodHemp seed line to California growers. The company is partnering with Grow West, one of the largest independent marketers of agricultural products in the state, and Buttonwillow Warehouse Company (BWC), a family-owned and operated fertilizer and crop protection products company in central and Southern California. American Battery Metals Corporation (OTCMKTS:ABML) has officially confirmed its previously-announced $10 million strategic investment, with the full funding expected by April 19. The investment is from Newood Finance Solutions Limited, a corporation in Fiji doing business as Unifinance Limited which is an affiliate of VCM Group Pty Limited, American Battery Metals’ engineering, procurement and construction partner. The funding will allow Nevada-based American Battery Metals to pursue lithium-ion battery recycling and its advanced extraction technology. TRACON Pharmaceuticals Inc (NASDAQ:TCON) has named Saundra Pelletier, who currently heads up Evofem Biosciences Inc (NASDAQ:EVFM), as a new board director. Pelletier is currently CEO, president and an executive director, at Evofem, which is a clinical-stage biopharmaceutical company focused on women’s sexual and reproductive health. She is leading that firm's effort to bring Phexxi, a new, non-hormonal contraceptive candidate, to women. Pelletier was named San Diego Business Journal's 2019 Businesswoman of the Year. mCloud Technologies Corp (CVE:MCLD) said the TSX Venture Exchange has accepted for filing documentation relating to the asset purchase agreement dated February 9, 2020, between it and certain arms-length parties, whereby the company will acquire all of the assets of AirFusion Inc., an artificial intelligence (AI) visual inspection and monitoring technology provider based in Boston, and its subsidiary, AirFusion Europe GmbH, existing customer contacts and technologies under development from its partner in Warsaw, Poland. As partial consideration, the company will issue 200,000 common shares on closing and up to an additional 200,000 common shares within a one-year period upon the achievement of certain performance targets and conditions having been met. Dyadic International, Inc. (NASDAQ:DYAI) has said its chief financial officer Ping Rawson will be presenting at this year's New York City-based Spring Investor Summit being held March 25-26 which will now take place virtually, featuring over 500 registered executives and investors. The group noted that investors will still be able to view all the company presentations directly in the conference event platform on the event days, while 1:1's will now be scheduled and conducted via phone lines with a dedicated PIN for each meeting. Dyadic said its company presentation can be via a webcast on March 25th, 2020 at 2.40pm Eastern Standard Time (EST): https://www.webcaster4.com/Webcast/Page/2038/33639 Recruiter.com Group, Inc. (OTCMKTS:RCRT) also said it will be presenting at this year's New York City-based Investor Summit. It noted that the Investor Summit (formerly MicroCap Conference) is an exclusive, independent conference dedicated to connecting small-cap and micro-cap companies with qualified investors. The group added its presentation can also be viewed via a webcast on March 25 at 1.25pm EST: https://www.webcaster4.com/Webcast/Page/2038/33650

Full Article